Recombinant TNFRSF8 (Brentuximab Biosimilar) antibody
Reactivity: Human
ELISA, SPR, Func, FACS, BLI
Host: Human
Monoclonal
unconjugated
Recombinant Antibody
-
- Target See all TNFRSF8 (Brentuximab Biosimilar) products
- TNFRSF8 (Brentuximab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Human
- Expression System
- CHO Cells
-
Clonality
- Monoclonal
-
Conjugate
- This TNFRSF8 (Brentuximab Biosimilar) antibody is un-conjugated
- Application
- ELISA, Surface Plasmon Resonance (SPR), Functional Studies (Func), Flow Cytometry (FACS), Bio-Layer Interferometry (BLI)
- Purpose
- Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab)
- Sequence
- QIQLQQSGPE VVKPGASVKI SCKASGYTFT DYYITWVKQK PGQGLEWIGW IYPGSGNTKY NEKFKGKATL TVDTSSSTAF MQLSSLTSED TAVYFCANYG NYWFAYWGQG TQVTVSAAST KGPSVFPLAP SSKSTSGGTA ALGCLVKDYF PEPVTVSWNS GALTSGVHTF PAVLQSSGLY SLSSVVTVPS SSLGTQTYIC NVNHKPSNTK VDKKVEPKSC DKTHTCPPCP APELLGGPSV FLFPPKPKDT LMISRTPEVT CVVVDVSHED PEVKFNWYVD GVEVHNAKTK PREEQYNSTY RVVSVLTVLH QDWLNGKEYK CKVSNKALPA PIEKTISKAK GQPREPQVYT LPPSRDELTK NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS DGSFFLYSKL TVDKSRWQQG NVFSCSVMHE ALHNHYTQKS LSLSPG,DIVLTQSPAS LAVSLGQRAT ISCKASQSVD FDGDSYMNWY QQKPGQPPKV LIYAASNLES GIPARFSGSG SGTDFTLNIH PVEEEDAATY YCQQSNEDPW TFGGGTKLEI KRTVAAPSVF IFPPSDEQLK SGTASVVCLL NNFYPREAKV QWKVDNALQS GNSQESVTEQ DSKDSTYSLS STLTLSKADY EKHKVYACEV THQGLSSPVT KSFNRGEC
- Characteristics
- Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.38 kDa.
- Purity
- >95 %
- Isotype
- IgG1
-
anti-TNFRSF8 (Brentuximab Biosimilar) antibody
Research Grade Reactivity: Human ELISA Host: Mouse Chimeric unconjugated Recombinant Antibody
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Comment
-
Therapeutic Agents by Target and Mechanism: CD30 inhibitors
Conditions: Anaplastic Large Cell Lymphoma Hematologic malignancies Hodgkin Lymphoma
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Concentration
- 1 mg/mL
- Buffer
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
- Storage
- 4 °C,-80 °C
- Storage Comment
- +4°C,-80°C
-
- Target
- TNFRSF8 (Brentuximab Biosimilar)
- Abstract
- TNFRSF8 (Brentuximab Biosimilar) Products
- Target Type
- Biosimilar
- Background
- Synonyms: TNFRSF8
- Molecular Weight
- 145.38 kDa
- UniProt
- P28908
-
You are here:
